Search Results - "Yallop, Christopher"

First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1 by Stephenson, Kathryn E, Keefer, Michael C, Bunce, Catherine A, Frances, Doreen, Abbink, Peter, Maxfield, Lori F, Neubauer, George H, Nkolola, Joseph, Peter, Lauren, Lane, Christopher, Park, Harriet, Verlinde, Carl, Lombardo, Angela, Yallop, Christopher, Havenga, Menzo, Fast, Patricia, Treanor, John, Barouch, Dan H

“…Live, attenuated viral vectors that express HIV-1 antigens are being investigated as an approach to generating durable immune responses against HIV-1 in…”
Get full text

Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries by Kumar, Prashant, Shukla, Ravi S., Patel, Ashaben, Pullagurla, Swathi R., Bird, Christopher, Ogun, Oluwadara, Kumru, Ozan S., Hamidi, Ahd, Hoeksema, Femke, Yallop, Christopher, Bines, Julie E., Joshi, Sangeeta B., Volkin, David B.

“…Formulation development was performed with the live, attenuated, human neonatal rotavirus vaccine candidate (RV3-BB) with three main objectives to facilitate…”
Get full text

Challenges in manufacturing adenoviral vectors for global vaccine product deployment by Vellinga, Jort, Smith, J Patrick, Lipiec, Agnieszka, Majhen, Dragomira, Lemckert, Angelique, van Ooij, Mark, Ives, Paul, Yallop, Christopher, Custers, Jerome, Havenga, Menzo

“…Abstract Once adenovirus vector-based vaccines are licensed for the prevention of important infectious diseases, manufacturing processes capable of reliably…”
Get more information

High throughput AS LNA qPCR method for the detection of a specific mutation in poliovirus vaccine strains by Opmeer, Lizet, Gazzoli, Isabella, Ballmann, Mónika, Willemsen, Marieke, Voshol, Gerben P., Grudniewska-Lawton, Magda, Havenga, Menzo, Yallop, Christopher, Hamidi, Ahd, Gillissen, Gert, Bakker, Wilfried A.M.

“…•AS LNA qPCR can accurately identify VP1-E295K containing samples in sPV2 batches.•The developed AS LNA qPCR for E295K mutation is highly sensitive.•LNA probes…”
Get full text

Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine by Hamidi, Ahd, Hoeksema, Femke, Velthof, Pim, Lemckert, Angelique, Gillissen, Gert, Luitjens, Alfred, Bines, Julie E., Pullagurla, Swathi R., Kumar, Prashant, Volkin, David B., Joshi, Sangeeta B., Havenga, Menzo, Bakker, Wilfried A.M., Yallop, Christopher

“…•A low-cost manufacturing process for a neonatal rotavirus vaccine was developed.•The formulation process developed resulted in a stable liquid vaccine at…”
Get full text

Modeling the long-term 2-8 °C stability profiles of a live, rotavirus vaccine candidate (RV3-BB) in various liquid formulations via extrapolations of real-time and accelerated stability data by Pullagurla, Swathi R., Kumar, Prashant, Ogun, Oluwadara, Kumru, Ozan S., Hamidi, Ahd, Hoeksema, Femke, Yallop, Christopher, Bines, Julie E., Volkin, David B., Joshi, Sangeeta B.

“…To accelerate the formulation development of live-virus vaccine (LVV) candidates, more rapid approaches to rank-order formulations and estimate their real-time…”
Get full text

The effects of G418 on the growth and metabolism of recombinant mammalian cell lines by YALLOP, Christopher Adam, SVENDSEN, Ivan

“…It is widely reported that the growth of recombinant bacteria and yeast is adversely affected by increased metabolic load caused by the maintenance of plasmid…”
Get full text